Researchers sought to develop and validate artificial neural networks for overall survival and progression-free survival in older adults with HNSCC following definitive chemoradiation.

Completed enrollment in Part B of SIGNAL-AA Phase 2a clinical trial and increased trial size to 33 patients based on patient demand; topline data readout expected ...

A Swedish study of more than 2 million women found that breast cancer risk linked to hormonal contraception depends strongly ...

The breaking of immune tolerance against autologous angiogenic endothelial cells should be a useful approach for cancer therapy. Here we show that immunotherapy of tumors using fixed xenogeneic whole ...

These questions come from my Udemy training and the certificationexams.pro website, resources that have helped many students pass the DP-100 certification. These are not DP-100 exam dumps or ...

Bayer Aktiengesellschaft ( OTCPK:BAYRY) Q3 2025 Earnings Call November 12, 2025 8:00 AM EST ...

Q3 2025 Earnings Call November 10, 2025 8:30 AM ESTCompany ParticipantsKate Rausch - Head of Investor RelationsPaul Bolno ...

The Scottish Medicines Consortium (SMC) announced today that they have accepted Kisqali (ribociclib) for use within NHS Scotland as an adjuvant treatment option in combination with an aromatase ...